PRESS RELEASE

Q3 2020 — Press release

Q3 2020PDF · 22 pages153 KB
October 27, 2020
3M Reports Third-Quarter 2020 Results
Third-Quarter Highlights:
Sales of $8.4 billion, up 4.5 percent year-on-year
Organic local-currency sales growth of 0.9 percent year-on-year
Both GAAP and adjusted EPS of $2.43
Operating cash flow of $2.5 billion, up 23 percent year-on-year; adjusted free
cash flow of $2.2 billion, up 13 percent year-on-year
Strengthened capital structure: reduced total debt by $1.2 billion, down 6
percent, and net debt by $1.3 billion, or 8 percent, since June 30, 2020
Company will continue to provide monthly sales updates through year-end 2020
ST. PAUL, Minn.--(BUSINESS WIRE)-- 3M (NYSE: MMM) today reported third-quarter 2020
results.
“Our third-quarter performance demonstrated once again the strength of the 3M model as
we executed well, served customers and continued to fight the pandemic,” said Mike Roman,
3M chairman and chief executive officer. “Though economic uncertainty and challenges due
to the COVID-19 pandemic remain, we returned to positive organic sales growth with
sequential improvement across businesses and geographies. We posted another quarter of
robust cash flow, aggressively managed costs and further strengthened our balance sheet.
“We continue to take actions to transform 3M and position us to deliver strong results as our
end markets recover,” Roman continued. “We will invest where demand is strong,
aggressively manage our cost structure, and create new innovations that address customer
needs and global market trends.”
Third-Quarter Results
The COVID-19 pandemic continues to evolve and affect 3M’s businesses in a number of
ways. The company saw sequential improvements across businesses, end markets and
geographies. During the third quarter, end-market demand remained strong in personal
safety, home improvement, general cleaning, semiconductor, data center and biopharma
filtration. At the same time, several other end markets, while improving, continued to
experience year-on-year declines primarily driven by COVID-19-related headwinds, including
healthcare and oral care elective procedures, auto OEM, general industrial, consumer
electronics, hospitality, office supplies, healthcare IT, and traffic safety.
Third-quarter sales grew 4.5 percent year-on-year to $8.4 billion. Organic local-currency
sales grew 0.9 percent, while acquisitions, net of divestitures, increased sales by 3.0
percent. Foreign currency translation increased sales by 0.6 percent year-on-year.
Total sales grew 25.5 percent year-on-year in Health Care, 6.9 percent in Safety and
Industrial, and 5.6 percent in Consumer, with a decline of 7.4 percent in Transportation and
Electronics. Organic local-currency sales increased 8.1 percent year-on-year in Health Care,

-- 1 of 22 --

6.9 percent in Safety and Industrial, and 5.5 percent in Consumer, with a decrease of 7.1
percent in Transportation and Electronics.
On a geographic basis, total sales grew 7.7 percent year-on-year in the Americas, 4.4
percent in EMEA (Europe, Middle East, and Africa), with a decline of 0.6 percent in Asia
Pacific. Organic local-currency sales grew 3.4 percent year-on-year in the Americas, and
declined 0.3 percent in EMEA and 2.6 percent in Asia Pacific.
Both third-quarter GAAP and adjusted earnings were $2.43 per share, resulting in year-on-
year declines of 10.7 percent and 5.8 percent on a GAAP- and adjusted-basis, respectively.
Third-quarter operating income was $1.9 billion with operating margins of 22.9 percent, as
referenced in the “Supplemental Financial Information Non-GAAP Measures” section.
The company’s operating cash flow was $2.5 billion with adjusted free cash flow of $2.2
billion contributing to adjusted free cash flow conversion of 153 percent. 3M paid $847
million in cash dividends to shareholders during the third quarter. The company reduced
total debt by $1.2 billion, down 6 percent, and net debt by $1.3 billion, or 8 percent,
sequentially. See the “Supplemental Financial Information Non-GAAP Measures” section for
applicable information.
Third-Quarter Business Group Discussion
Safety and Industrial
Sales of $3.0 billion, up 6.9 percent year-on-year in U.S. dollars. Organic local-
currency sales increased 6.9 percent, foreign currency translation increased sales by
0.4 percent, and divestitures decreased sales by 0.4 percent.
On an organic local-currency basis:
Sales increased in personal safety, roofing granules, and automotive aftermarket;
sales declined in electrical markets, industrial adhesives and tapes, closure and
masking systems, and abrasives.
Sales grew in the Americas and EMEA; sales declined in Asia Pacific.
Segment operating income was $823 million, an increase of 27.2 percent year-on-
year; operating margins of 27.2 percent.
Transportation and Electronics
Sales of $2.3 billion, down 7.4 percent year-on-year in U.S. dollars. Organic local-
currency sales decreased 7.1 percent, foreign currency translation increased sales by
0.9 percent, and divestitures decreased sales by 1.2 percent.
On an organic local-currency basis:
Sales increased in electronics; sales declined in transportation safety,
commercial solutions, automotive and aerospace, and advanced materials.
Sales declined in Asia Pacific, the Americas, and EMEA.
Segment operating income was $552 million, a decline of 13.2 percent year-on-year;
operating margins of 23.9 percent.
Health Care
Sales of $2.2 billion, up 25.5 percent year-on-year in U.S. dollars. Organic local-

-- 2 of 22 --

currency sales increased 8.1 percent, foreign currency translation increased sales by
1.1 percent and acquisitions, net of divestitures, increased sales by 16.3 percent.
On an organic local-currency basis:
Sales grew in medical solutions, separation and purification, and oral care; sales
declined in food safety and health information systems.
Sales increased in the Americas and EMEA; sales declined in Asia Pacific.
Segment operating income was $508 million, an increase of 10.6 percent year-on-
year; operating margins of 23.5 percent.
Consumer
Sales of $1.4 billion, up 5.6 percent year-on-year in U.S. dollars. Organic local-
currency sales increased 5.5 percent and foreign currency translation increased sales
by 0.1 percent.
On an organic local-currency basis:
Sales grew in home care, and home improvement; were flat in consumer health
care and declined in stationery and office supplies.
Sales increased in the Americas and EMEA; sales declined in Asia Pacific.
Segment operating income was $358 million, up 14.7 percent year-on-year; operating
margins of 25.3 percent.
Outlook
Due to the continued evolving and uncertain impact of the COVID-19 pandemic, 3M is not
able to estimate the full duration, magnitude and pace of recovery across its diverse end
markets with reasonable accuracy. Therefore, 3M continues to believe it is prudent to not
provide guidance. 3M will maintain its monthly reporting of sales information during the
fourth-quarter to continue to provide transparency on its ongoing business performance.
The company estimates total sales for October to be flat to up low-single digits year-on-year.
This estimate includes the anticipated impact of one fewer business day in October 2020
versus October 2019.
3M will conduct an investor teleconference at 9:00 a.m. EDT (8:00 a.m. CDT) today.
Investors can access this conference via the following:
Live webcast at http://investors.3M.com.
Live telephone:
Call 800-762-2596 within the U.S. or +1 212-231-2916 outside the U.S. Please join the
call at least 10 minutes before the start time.
Webcast replay:
Go to 3M’s Investor Relations website at http://investors.3M.com and click on
“Quarterly Earnings.”
Telephone replay:
Call 800-633-8284 within the U.S. or +1 402-977-9140 outside the U.S. (for both U.S.
and outside the U.S., the access code is 21930639). The telephone replay will be
available until 11:30 a.m. EST (10:30 a.m. CST) on November 3, 2020.
Forward-Looking Statements
This news release contains forward-looking information about 3M's financial results and

-- 3 of 22 --

estimates and business prospects that involve substantial risks and uncertainties. You can
identify these statements by the use of words such as "anticipate," "estimate," "expect,"
"aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and
other words and terms of similar meaning in connection with any discussion of future
operating or financial performance or business plans or prospects. Among the factors that
could cause actual results to differ materially are the following: (1) worldwide economic,
political, regulatory, capital markets and other external conditions and other factors beyond
the Company's control, including natural and other disasters or climate change affecting the
operations of the Company or its customers and suppliers; (2) risks related to public health
crises such as the global pandemic associated with the coronavirus (COVID-19); (3)
liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-
related products and chemistries, and claims and governmental regulatory proceedings and
inquiries related to PFAS in a variety of jurisdictions; (4) legal proceedings, including
significant developments that could occur in the legal and regulatory proceedings described
in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2019, and any
subsequent quarterly reports on Form 10-Q (the “Reports”); (5) competitive conditions and
customer preferences; (6) foreign currency exchange rates and fluctuations in those rates;
(7) the timing and market acceptance of new product offerings; (8) the availability and cost of
purchased components, compounds, raw materials and energy (including oil and natural gas
and their derivatives) due to shortages, increased demand or supply interruptions (including
those caused by natural and other disasters and other events); (9) unanticipated problems or
delays with the phased implementation of a global enterprise resource planning (ERP)
system, or security breaches and other disruptions to the Company's information technology
infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures and other
unusual events resulting from portfolio management actions and other evolving business
strategies, and possible organizational restructuring; (11) operational execution, including
scenarios where the Company generates fewer productivity improvements than estimated;
(12) financial market risks that may affect the Company’s funding obligations under defined
benefit pension and postretirement plans; and (13) the Company's credit ratings and its cost
of capital. Changes in such assumptions or factors could produce significantly different
results. A further description of these factors is located in the Reports under "Cautionary
Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items
1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports), as
updated by applicable Current Reports on Form 8-K. The information contained in this news
release is as of the date indicated. The Company assumes no obligation to update any
forward-looking statements contained in this news release as a result of new information or
future events or developments.
3M Company and Subsidiaries
CONSOLIDATED STATEMENT OF INCOME
(Millions, except per-share amounts)
(Unaudited)
Three months ended 	Nine months ended
September 30, 	September 30,
2020 	2019 	2020 	2019
Net sales 	$ 8,350 $ 7,991 $ 23,601 $ 24,025

-- 4 of 22 --

Operating expenses
Cost of sales 	4,303 	4,188 	12,217 	12,811
Selling, general and administrative
expenses 	1,677 	1,455 	5,039 	5,089
Research, development and related
expenses 	461 	443 	1,422 	1,390
Gain on sale of businesses 	— 	(106) 	(389) 	(114)
Total operating expenses 	6,441 	5,980 	18,289 	19,176
Operating income 	1,909 	2,011 	5,312 	4,849
Other expense (income), net 	104 	45 	311 	349
Income before income taxes 	1,805 	1,966 	5,001 	4,500
Provision for income taxes 	387 	378 	1,002 	888
Income of consolidated group 	1,418 	1,588 	3,999 	3,612
Income (loss) from unconsolidated
subsidiaries, net of taxes 	(1) 	— 	(1) 	—
Net income including noncontrolling
interest 	1,417 	1,588 	3,998 	3,612
Less: Net income (loss) attributable to
noncontrolling interest 	4 	5 	3 	11
Net income attributable to 3M 	$ 1,413 $ 1,583 $ 3,995 $ 3,601
Weighted average 3M common shares
outstanding – basic 	577.8 	576.5 	577.2 	577.2
Earnings per share attributable to 3M
common shareholders – basic 	$ 	2.45 $ 	2.75 $ 6.92 $ 	6.24
Weighted average 3M common shares
outstanding – diluted 	582.4 	583.0 	581.6 	585.9
Earnings per share attributable to 3M
common shareholders – diluted 	$ 	2.43 $ 	2.72 $ 6.87 $ 	6.15
3M Company and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(Unaudited)
September 30, December 31,

-- 5 of 22 --

2020 	2019
ASSETS
Current assets
Cash and cash equivalents 	$ 	4,121 $ 	2,353
Marketable securities – current 	440 	98
Accounts receivable – net 	4,623 	4,791
Inventories 	3,984 	4,134
Prepaids 	516 	704
Other current assets 	426 	891
Total current assets 	14,110 	12,971
Property, plant and equipment – net 	9,216 	9,333
Operating lease right of use assets 	844 	858
Goodwill and intangible assets – net 	19,461 	19,823
Other assets 	1,759 	1,674
Total assets 	$ 	45,390 $ 	44,659
LIABILITIES AND EQUITY
Current liabilities
Short-term borrowings and
current portion of long-term debt 	$ 	1,169 $ 	2,795
Accounts payable 	2,208 	2,228
Accrued payroll 	721 	702
Accrued income taxes 	220 	194
Operating lease liabilities – current 	252 	247
Other current liabilities 	2,840 	3,056
Total current liabilities 	7,410 	9,222
Long-term debt 	18,429 	17,518
Other liabilities 	7,608 	7,793
Total liabilities 	$ 	33,447 $ 	34,533
Total equity 	$ 	11,943 $ 	10,126
Shares outstanding
September 30, 2020: 576,821,878 shares
December 31, 2019: 575,184,835 shares
Total liabilities and equity 	$ 	45,390 $ 	44,659
3M Company and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)
Nine months ended

-- 6 of 22 --

September 30,
2020 	2019
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 	$ 5,598 $ 4,732
Cash flows from investing activities:
Purchases of property, plant and equipment 	(1,079) 	(1,161)
Acquisitions, net of cash acquired 	(25) 	(704)
Purchases and proceeds from sale or maturities of marketable
securities and investments – net 	170 	348
Proceeds from sale of businesses, net of cash sold 	576 	236
Other investing activities 	37 	136
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 	(321) 	(1,145)
Cash flows from financing activities:
Change in debt (870) 	4,779
Purchases of treasury stock 	(366) 	(1,243)
Proceeds from issuances of treasury stock pursuant to stock option
and benefit plans 	325 	437
Dividends paid to shareholders 	(2,540) 	(2,488)
Other financing activities 	(47) 	(158)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 	(3,498) 	1,327
Effect of exchange rate changes on cash and cash equivalents 	(11) 	(36)
Net increase (decrease) in cash and cash equivalents 	1,768 	4,878
Cash and cash equivalents at beginning of year 	2,353 	2,853
Cash and cash equivalents at end of period 	$ 4,121 $ 7,731
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)
(Dollars in
millions,
except per
share
amounts)
Operating
Income
Operating
Income
Margin
Income
Before
Taxes
Provision
for
Income
Taxes
Effective
Tax
Rate
Net Income
Attributable
to 3M
Earnings
Per
Diluted
Share
Earnings
diluted
share
percent
change

-- 7 of 22 --

Q3 2019
GAAP 	$ 2,011 	25.2% $ 1,966 $ 	378 	19.3% $ 	1,583 $ 2.72
Adjustments
for special
items:
(Gain)/loss
on sale of
businesses 	(106) 	(106) 	(27) 	(79) 	(0.14)
Q3 2019
adjusted
amounts
(non-GAAP
measures)
(a) 	$ 1,905 	23.8% $ 1,860 $ 	351 	19.0% $ 	1,504 $ 2.58
Q3 2020
GAAP 	$ 1,909 	22.9% $ 1,805 $ 	387 	21.4% $ 	1,413 $ 2.43 (10.7
Adjustments
for special
items:
None
Q3 2020
adjusted
amounts
(non-GAAP
measures)
(a) 	$ 1,909 	22.9% $ 1,805 $ 	387 	21.4% $ 	1,413 $ 2.43 (5.8
(Dollars in
millions, except
per share
amounts)
Operating
Income
Operating
Income
Margin
Income
Before
Taxes
Provision
for
Income
Taxes
Effective
Tax
Rate
Net Income
Attributable
to 3M
Earnings
Per
Diluted
Share
First nine months
2019 GAAP 	$ 4,849 	20.2% $ 4,500 $ 	888 19.7% $ 	3,601 $ 6.15
Adjustments for
special items:
Significant
litigation-related
charges/benefits 	548 	548 	124 	424 	0.72
Loss on
deconsolidation
of Venezuelan
subsidiary 	— 	162 	— 	162 	0.28

-- 8 of 22 --

(Gain)/loss on
sale of
businesses (114) 	(114) 	15 	(129) 	(0.22
First nine months
2019 adjusted
amounts (non-
GAAP measures)
(a) 	$ 5,283 	22.0% $ 5,096 $ 1,027 20.2% $ 	4,058 $ 6.93
First nine months
2020 GAAP 	$ 5,312 	22.5% $ 5,001 $ 1,002 20.0% $ 	3,995 $ 6.87
Adjustments for
special items:
Significant
litigation-related
charges/benefits 	17 	17 	56 	(39) 	(0.07
(Gain)/loss on
sale of
businesses 	(389) 	(389) 	(86) 	(303) 	(0.52
Divestiture-
related
restructuring
actions 	55 	55 	9 	46 	0.08
First nine months
2020 adjusted
amounts (non-
GAAP measures)
(a) 	$ 4,995 	21.2% $ 4,684 $ 	981 21.0% $ 	3,699 $ 6.36
(a) In addition to reporting financial results in accordance with U.S. GAAP, the Company
also provides non-GAAP measures that adjust for the impact of special items. Special
items for the periods presented include the items described in the section entitled
“Description of Special Items”. Beginning in 2020, the Company includes gain/loss on
sale of businesses and divestiture-related restructuring actions as special items due to
their potential distortion of underlying operating results. Information provided herein
reflects the impact of this change for all periods presented. Operating income, income
before taxes, net income, earnings per share, and effective tax rate are all measures for
which 3M provides the reported GAAP measure and a measure adjusted for special
items. The adjusted measures are not in accordance with, nor are they a substitute for,
GAAP measures. The Company considers these non-GAAP measures in evaluating and
managing the Company’s operations. The Company believes that discussion of results
adjusted for these items is meaningful to investors as it provides a useful analysis of
ongoing underlying operating trends. The determination of these items may not be
comparable to similarly titled measures used by other companies.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION

-- 9 of 22 --

NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Three months ended Nine months ended
September 30, 	September 30,
Major GAAP Cash Flow Categories
(dollars in millions) 	2020 	2019 	2020 	2019
Net cash provided by (used in) operating
activities 	$ 2,480 $ 2,022 $ 5,598 $ 4,732
Net cash provided by (used in) investing
activities 	(523) 	90 	(321) 	(1,145)
Net cash provided by (used in) financing
activities 	(2,097) 	2,804 	(3,498) 	1,327
Adjusted Free Cash Flow (non-GAAP
measure) (dollars in millions)
Net cash provided by (used in) operating
activities 	$ 2,480 $ 2,022 $ 5,598 $ 4,732
Purchases of property, plant and equipment 	(368) 	(349) 	(1,079) 	(1,161)
Free cash flow 	$ 2,112 $ 1,673 $ 4,519 $ 3,571
Adjustments for special items:
Significant litigation-related after-tax
payment impacts 	$ 	10 $ 229 $ 	74 $ 260
TCJA transition tax payments 	33 	— 	33 	—
Divestiture-related restructuring after-tax
payment impacts 	6 	9 	6 	54
Adjusted free cash flow (b) 	$ 2,161 $ 1,911 $ 4,632 $ 3,885
Net income attributable to 3M 	$ 1,413 $ 1,583 $ 3,995 $ 3,601
Adjustments for special items:
Significant litigation-related
charges/benefits 	— 	— 	(39) 	424
Loss on deconsolidation of Venezuelan
subsidiary 	— 	— 	— 	162
(Gain)/loss on sale of businesses 	— 	(79) 	(303) 	(129)
Divestiture-related restructuring actions 	— 	— 	46 	—
Adjusted net income attributable to 3M (a) 	$ 1,413 $ 1,504 $ 3,699 $ 4,058
Adjusted free cash flow conversion (b) 	153% 	127% 	125% 	96%

-- 10 of 22 --

(b) Adjusted free cash flow and adjusted free cash flow conversion are not defined under
U.S. GAAP. Therefore, they should not be considered a substitute for income or cash
flow data prepared in accordance with U.S. GAAP and may not be comparable to
similarly titled measures used by other companies. The Company defines adjusted free
cash flow as net cash provided by operating activities, adjusted for special items, less
purchases of property, plant and equipment. Cash payments associated with special
items in the determination of adjusted free cash flow are reflected net of applicable tax
using the U.S. statutory corporate tax rate during the period of payment. It should not be
inferred that the entire adjusted free cash flow amount is available for discretionary
expenditures. The Company defines adjusted free cash flow conversion as adjusted free
cash flow divided by net income attributable to 3M, adjusted for special items. Special
items for the periods presented include the items described in section entitled
“Description of Special Items”. The Company believes adjusted free cash flow and
adjusted free cash flow conversion are meaningful to investors as they are useful
measures of performance and the Company uses these measures as an indication of the
strength of the company and its ability to generate cash.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Adjusted EBITDA (non-GAAP measure) (c) Adjusted EBITDA Margin (non-GAAP me
Three months ended September 30, 	Three months ended September 3
(Dollars in
millions) 	2020 	2019 	2020
Safety and
Industrial 	$ 	956 $ 	753 	31.6%
Transportation
and
Electronics 	643 	716 	27.8
Health Care 	644 	512 	29.8
Consumer 	383 	337 	27.0
Corporate and
Unallocated 	(91) 	77
Elimination of
Dual Credit 	(145) 	(111)
Total
Company 	$ 	2,390 $ 	2,284 	28.6%
Adjusted EBITDA (non-GAAP measure) (c) Adjusted EBITDA Margin (non-GAAP me
Nine months ended September 30, 	Nine months ended September 3
(Dollars in
millions) 	2020 	2019 	2020

-- 11 of 22 --

Safety and
Industrial $ 	2,542 $ 	2,243 	29.5%
Transportation
and
Electronics 	1,673 	1,982 	25.8
Health Care 	1,667 	1,564 	27.4
Consumer 	981 	892 	25.1
Corporate and
Unallocated 	(71) 	40
Elimination of
Dual Credit 	(384) 	(308)
Total
Company 	$ 	6,408 $ 	6,413 	27.2%
Three months ended 	Nine months ended
Adjusted EBITDA (non-
GAAP measure)
(dollars in millions)
September 30,
2020
September 30,
2019
September 30,
2020
September 30,
2019
Net sales 	$ 	8,350 	$ 	7,991 	$ 	23,601 $ 	24,025
Net income attributable
to 3M 	1,413 	1,583 	3,995 	3,601
Add/(subtract):
Net income/(loss)
attributable to
noncontrolling interest 	4 	5 	3 	11
(Income)/Loss from
unconsolidated
subsidiaries, net of
taxes 	1 	— 	1 	—
Provision for income
taxes 	387 	378 	1,002 	888
Other
expense/(income):
Interest
(Income)/expense 	123 	83 	364 	260
Pension & OPEB
non-service cost
(benefit) 	(19) 	(38) 	(53) 	(73)
Loss on
deconsolidation of
Venezuelan
subsidiary 	— 	— 	— 	162

-- 12 of 22 --

Depreciation and
amortization expense 	481 	379 	1,413 	1,130
Adjustments for special
items:
Significant litigation-
related
charges/benefits 	— 	— 	17 	548
(Gain)/loss on sale of
businesses 	— 	(106) 	(389) 	(114)
Divestiture-related
restructuring actions 	— 	— 	55 	—
Adjusted EBITDA (c) 	$ 	2,390 	$ 	2,284 	$ 	6,408 $ 	6,413
Adjusted EBITDA margin
(c) 	28.6% 	28.6% 	27.2% 	26.7%
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Adjusted EBITDA
(non-GAAP
measure) Three
months ended
September 30,
2020 (dollars in
millions)
Safety and
Industrial
Transportation
and
Electronics Health Care Consumer
Corporate
and
Unallocated
Elimination
of Dual
Credit
Net sales 	$ 3,024 $ 	2,314 	$ 2,160 $ 1,417 $ 	— $
Business segment
operating income
(measure of
segment operating
performance) 	823 	552 	508 	358 	(187)
Add/(subtract):
Depreciation and
amortization 	133 	91 	136 	25 	96
Adjustments for
special items:
None
Adjusted EBITDA
(non-GAAP
measure) (c) 	$ 	956 $ 	643 	$ 	644 $ 383 $ 	(91) $

-- 13 of 22 --

Adjusted EBITDA
margin (non-GAAP
measure) (c) 31.6% 	27.8% 	29.8% 	27.0%
Adjusted EBITDA
(non-GAAP
measure) Three
months ended
September 30,
2019 (dollars in
millions)
Safety and
Industrial
Transportation
and
Electronics Health Care Consumer
Corporate
and
Unallocated
Elimination
of Dual
Credit
Net sales 	$ 2,829 $ 	2,500 	$ 1,721 $ 1,342 $ 	28 $
Business segment
operating income
(measure of
segment operating
performance) 	647 	637 	459 	313 	66
Add/(subtract):
Depreciation and
amortization 	106 	79 	53 	24 	117
Adjustments for
special items:
(Gain)/loss on
sale of
businesses 	(106)
Adjusted EBITDA
(non-GAAP
measure) (c) 	$ 	753 $ 	716 	$ 	512 $ 337 $ 	77 $
Adjusted EBITDA
margin (non-GAAP
measure) (c) 	26.6% 	28.6% 	29.8% 	25.1%
Adjusted EBITDA
(non-GAAP
measure) Nine
months ended
September 30,
2020 (dollars in
millions)
Safety and
Industrial
Transportation
and
Electronics Health Care Consumer
Corporate
and
Unallocated
Elimination
of Dual
Credit
Net sales 	$ 8,627 $ 	6,489 	$ 6,088 $ 3,911 $ 	(1) $

-- 14 of 22 --

Business segment
operating income
(measure of
segment operating
performance)
2,185 	1,416 	1,270 	914 	(89)
Add/(subtract):
Depreciation and
amortization 	357 	257 	397 	67 	335
Adjustments for
special items:
Significant
litigation-related
charges/benefits 	17
(Gain)/loss on
sale of
businesses 	(389)
Divestiture-
related
restructuring
actions 	55
Adjusted EBITDA
(non-GAAP
measure) (c) 	$ 2,542 $ 	1,673 	$ 1,667 $ 981 $ 	(71) $
Adjusted EBITDA
margin (non-GAAP
measure) (c) 	29.5% 	25.8% 	27.4% 	25.1%
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Adjusted EBITDA
(non-GAAP
measure) Nine
months ended
September 30,
2019 (dollars in
millions)
Safety and
Industrial
Transportation
and
Electronics Health Care Consumer
Corporate
and
Unallocated
Elimination
of Dual
Credit
Net sales 	$ 8,729 $ 	7,305 	$ 5,290 $ 3,862 $ 	98 $

-- 15 of 22 --

Business segment
operating income
(measure of
segment operating
performance) 1,931 	1,747 	1,401 	821 	(743)
Add/(subtract):
Depreciation and
amortization 	312 	235 	163 	71 	349
Adjustments for
special items:
Significant
litigation-related
charges/benefits 	548
(Gain)/loss on
sale of
businesses 	(114)
Adjusted EBITDA
(non-GAAP
measure) (c) 	$ 2,243 $ 	1,982 	$ 1,564 $ 892 $ 	40 $
Adjusted EBITDA
margin (non-GAAP
measure) (c) 25.7% 	27.1% 	29.6% 	23.1%
(c) Adjusted EBITDA and adjusted EBITDA margin are not defined under U.S. GAAP.
Therefore, adjusted EBITDA and adjusted EBITDA margin should not be considered a
substitute for other measures prepared in accordance with U.S. GAAP and may not be
comparable to similarly titled measures used by other companies. The Company defines
adjusted EBITDA as net income attributable to 3M, adjusted for net income/(loss)
attributable to noncontrolling interest, (income)/loss from unconsolidated subsidiaries,
provision for income taxes, other expense/(income), depreciation and amortization
expense, and special items. For business segments, the Company defines adjusted
EBITDA as business segment operating income (3M’s measure of segment operating
performance) adjusted for depreciation and amortization expense. The Company defines
adjusted EBITDA margin as adjusted EBITDA divided by net sales. Special items for the
periods presented include the items described in the section entitled “Description of
Special Items”. The Company considers these non-GAAP measures in evaluating and
managing the Company’s operations. The Company believes adjusted EBITDA and
adjusted EBITDA margin are meaningful to investors as they provide useful analyses of
ongoing underlying operating trends.
September 30, December 31,
Net Debt (non-GAAP measure) 	2020 	2019
Total debt 	$ 	19,598 $ 	20,313
Less: Cash, cash equivalents and marketable securities 	4,595 	2,494

-- 16 of 22 --

Net debt (d) 	$ 	15,003 $ 	17,819
(d) Net debt is not defined under U.S. GAAP and may not be computed the same as
similarly titled measures used by other companies. The Company defines net debt as
total debt less the total of cash, cash equivalents and current and long-term marketable
securities. 3M believes net debt is meaningful to investors as 3M considers net debt and
its components to be an important indicator of liquidity and a guiding measure of capital
structure strategy.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Description of Special Items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also
provides various non-GAAP measures that incorporate adjustments for the impacts of
special items. Special items incorporated in the preparation of these non-GAAP measures
for the periods presented include the items described below:
Significant litigation-related charges/benefits:
In the first quarter of 2020, 3M recorded a net pre-tax charge of $17 million ($13 million
after tax) related to PFAS (certain perfluorinated compounds) matters. The charge was
more than offset by a reduction in tax expense of $52 million related to resolution of tax
treatment with authorities regarding the previously disclosed 2018 agreement reached
with the State of Minnesota that resolved the Natural Resources Damages (NRD)
lawsuit. These items, in aggregate, resulted in a $39 million after tax benefit. In the
third quarter and first nine months of 2020, 3M made payments of approximately $13
million and $94 million, respectively, related to significant litigation-related matters.
In the first quarter of 2019, 3M recorded significant litigation-related charges of $548
million ($424 million after tax) related to historical PFAS manufacturing operations and
coal mine dust respirator mask lawsuits. In the third quarter and first nine months of
2019, 3M made payments of approximately $290 million and $329 million, respectively,
related to significant litigation-related matters.
Loss on deconsolidation of Venezuelan subsidiary:
In the second quarter of 2019, 3M recorded a pre-tax charge of $162 million related to
the deconsolidation of the Company’s Venezuelan subsidiary.
Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA)
In the third quarter of 2020, 3M made payments of approximately $33 million related to
the transition tax expense incurred as a result of the 2017 enactment of the TCJA.
Gain/loss on sale of businesses:
In the first quarter of 2020, 3M recorded a pre-tax gain of $2 million ($1 million loss
after tax) related to the sale of its advanced ballistic-protection business and

-- 17 of 22 --

recognition of certain contingent consideration. In the second quarter of 2020, 3M
recorded a pre-tax gain of $387 million ($304 million after tax) related to the sale of its
drug delivery business.
In the first quarter of 2019, 3M recorded a gain related to the sale of certain oral care
technology comprising a business in addition to reflecting an earnout on a previous
divestiture, which together resulted in a net gain of $8 million ($7 million after tax). In
the second quarter of 2019, as a result of a “held for sale” tax benefit related to the
legal entities associated with the pending divestiture of the Company’s gas and flame
detection business, 3M recorded an after tax gain of $43 million. In the third quarter of
2019, 3M recorded a gain related to the divestiture of the Company’s gas and flame
detection business and an immaterial impact as a result of measuring a disposal group
at the lower of its carrying amount or fair value less cost to sell, which in aggregate
resulted in a pre-tax gain of $106 million ($79 million after tax).
Divestiture-related restructuring actions:
In the second quarter 2020, following the divestiture of substantially all of the drug
delivery business, management approved and committed to undertake certain
restructuring actions addressing corporate functional costs and manufacturing footprint
across 3M in relation to the magnitude of amounts previously allocated/burdened to
the divested business. As a result, 3M recorded a pre-tax charge of $55 million ($46
million after tax). In both the third quarter and first nine months of 2020, 3M made
payments of approximately $7 million associated with these restructuring charges.
In the third quarter and first nine months of 2019, 3M made payments of approximately
$11 million and $68 million, respectively, associated with restructuring charges taken in
2018 related to addressing corporate functional costs following the 2018
Communication Markets Division divestiture.
3M Company and Subsidiaries
SALES CHANGE ANALYSIS (e)
(Unaudited)
Three months ended September 30, 2020
Europe,
Middle
Sales Change Analysis 	Asia- 	East and 	World-
By Geographic Area 	Americas 	Pacific 	Africa 	Wide
Volume – organic 	2.3% 	(1.8)% 	(1.8)% 	0.3%
Price 	1.1 	(0.8) 	1.5 	0.6
Organic local-currency sales 	3.4 	(2.6) 	(0.3) 	0.9
Acquisitions 	7.5 	1.0 	4.1 	4.8
Divestitures 	(1.8) 	(0.6) 	(4.0) 	(1.8)
Translation 	(1.4) 	1.6 	4.6 	0.6
Total sales change 	7.7% 	(0.6)% 	4.4% 	4.5%

-- 18 of 22 --

Three months ended September 30, 2020
Worldwide Sales
Change 	Organic local- 	Total sales
By Business
Segment 	currency sales Acquisitions Divestitures Translation change
Safety and Industrial 	6.9% 	—% 	(0.4)% 	0.4% 	6.9%
Transportation and
Electronics 	(7.1) 	— 	(1.2) 	0.9 	(7.4)
Health Care 	8.1 	23.4 	(7.1) 	1.1 	25.5
Consumer 	5.5 	— 	— 	0.1 	5.6
Total Company 	0.9% 	4.8% 	(1.8)% 	0.6% 	4.5%
Nine months ended September 30, 2020
Europe,
Middle
Sales Change Analysis 	Asia- 	East and 	World-
By Geographic Area 	Americas 	Pacific 	Africa 	Wide
Volume – organic 	(3.8)% 	(4.5)% 	(6.7)% 	(4.6)%
Price 	0.9 	(0.5) 	1.1 	0.5
Organic local-currency sales 	(2.9) 	(5.0) 	(5.6) 	(4.1)
Acquisitions 	7.1 	0.9 	3.6 	4.5
Divestitures 	(1.5) 	(0.2) 	(2.7) 	(1.3)
Translation 	(1.4) 	(0.5) 	(0.2) 	(0.9)
Total sales change 	1.3% 	(4.8)% 	(4.9)% 	(1.8)%
Nine months ended September 30, 2020
Worldwide Sales
Change 	Organic local- 	Total sales
By Business
Segment 	currency sales Acquisitions Divestitures Translation change
Safety and Industrial 	0.9% 	—% 	(0.8)% 	(1.3)% 	(1.2)%
Transportation and
Electronics 	(9.8) 	— 	(1.0) 	(0.4) 	(11.2)
Health Care 	(1.3) 	20.9 	(3.7) 	(0.8) 	15.1
Consumer 	2.1 	— 	— 	(0.8) 	1.3
Total Company 	(4.1)% 	4.5% 	(1.3)% 	(0.9)% 	(1.8)%
(e) Total sales change is calculated based on reported sales results. The components of
sales change include organic local-currency sales, acquisitions, divestitures, and
translation. Organic local-currency sales includes both organic volume impacts (which
excludes acquisition and divestiture impacts), and selling price changes. Acquisition and
divestiture impacts are measured separately for the first 12 months post-transaction.
3M Company and Subsidiaries

-- 19 of 22 --

BUSINESS SEGMENTS
(Unaudited)
Effective in the second quarter of 2020, the measure of segment operating performance
used by 3M’s chief operating decision maker (CODM) changed and, as a result, 3M’s
disclosed measure of segment profit/loss (business segment operating income) has been
updated for all periods presented. The change to business segment operating income aligns
with the update to how the CODM assesses performance and allocates resources for the
Company’s business segments.
3M discloses business segment operating income as its measure of segment profit/loss,
reconciled to both total 3M operating income and income before taxes. Business segment
operating income includes dual credit for certain related operating income (as described
below in “Elimination of Dual Credit”). Business segment operating income excludes certain
expenses and income that are not allocated to business segments (as described below in
“Corporate and Unallocated”). Additionally, the following special items are excluded from
business segment operating income and, instead, are included within Corporate and
Unallocated: significant litigation-related charges/benefits, gain/loss on sale of businesses,
and divestiture-related restructuring actions.
In addition, effective in the first quarter of 2020, in a continuing effort to improve the
alignment of its businesses around customers and markets, the Company made the
following changes:
Continued alignment of customer account activity
As part of 3M’s regular customer-focus initiatives, the Company realigned certain
customer account activity (“sales district”) to correlate with the primary divisional
product offerings in various countries and reduce complexity for customers when
interacting with multiple 3M businesses. This largely impacted the amount of dual
credit certain business segments receive as a result of sales district attribution. 3M
business segment reporting measures include dual credit to business segments for
certain sales and operating income. This dual credit is based on which business
segment provides customer account activity with respect to a particular product sold in
a specific country.
Additional actions impacting product line alignments
The remaining retail auto care product lines formerly in the Automotive Aftermarket
Division (within the Safety and Industrial business segment) were realigned to the
Construction and Home Improvement Division (within the Consumer business
segment).
In addition, certain product lines were realigned within business segments. The
transdermal drug delivery components business, formerly included in the Drug Delivery
Systems Division was realigned to the Medical Solutions Division (both of which are
within the Health Care business segment) and the paint protection film business,
formerly included in the Automotive and Aerospace Division was realigned to the
Commercial Solutions Division (both of which are within the Transportation and
Electronics business segment).

-- 20 of 22 --

The financial information presented herein reflects the impact of these changes for all
periods presented.
BUSINESS SEGMENT
INFORMATION 	Three months ended 	Nine months ended
NET SALES 	September 30, 	September 30,
(Millions) 	2020 	2019 	2020 	2019
Safety and Industrial 	$ 3,024 	$ 2,829 $ 8,627 $ 8,729
Transportation and Electronics 	2,314 	2,500 	6,489 	7,305
Health Care 	2,160 	1,721 	6,088 	5,290
Consumer 	1,417 	1,342 	3,911 	3,862
Corporate and Unallocated 	— 	28 	(1) 	98
Elimination of Dual Credit 	(565) 	(429) 	(1,513) 	(1,259)
Total Company 	$ 8,350 	$ 7,991 $ 23,601 $ 24,025
3M Company and Subsidiaries
BUSINESS SEGMENTS – (CONTINUED)
(Unaudited)
BUSINESS SEGMENT INFORMATION 	Three months ended 	Nine months ended
OPERATING INCOME 	September 30, 	September 30,
(Millions) 	2020 	2019 	2020 	2019
Safety and Industrial 	$ 	823 $ 	647 $ 2,185 $ 1,931
Transportation and Electronics 	552 	637 	1,416 	1,747
Health Care 	508 	459 	1,270 	1,401
Consumer 	358 	313 	914 	821
Elimination of Dual Credit 	(145) 	(111) 	(384) 	(308)
Total business segment operating
income 	$ 2,096 	$ 1,945 $ 5,401 $ 5,592
Corporate and Unallocated
Special items:
Significant litigation-related
(charges)/benefits 	— 	— 	(17) 	(548)
Gain/(loss) on sale of businesses 	— 	106 	389 	114
Divestiture-related restructuring
actions — 	— 	(55) 	—
Other corporate expense - net 	(187) 	(40) 	(406) 	(309)
Total Corporate and Unallocated 	$ (187) $ 	66 $ 	(89) $ (743)
Total Company operating income 	$ 1,909 $ 2,011 $ 5,312 $ 4,849
Other expense/(income), net 	$ 	104 $ 	45 $ 	311 $ 	349
Income before income taxes 	$ 1,805 $ 1,966 $ 5,001 $ 4,500

-- 21 of 22 --

About 3M
At 3M, we apply science in collaborative ways to improve lives daily. With $32 billion in
sales, our 96,000 employees connect with customers all around the world. Learn more about
3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or
@3MNews.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201027005466/en/
3M
Investor Contacts:
Bruce Jermeland, 651-733-1807
or
Tony Riter, 651-733-1141
or
Media Contact:
Stephen Sanchez, 651-737-5967
Source: 3M

-- 22 of 22 --